• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Model Number JADA-1001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 10/24/2021
Event Type  Injury  
Event Description
The patient was reported to have preeclampsia with severe features this pregnancy, gestational hypertension, and uterine fibroids.She presented for delivery of a singleton at 35.3 weeks and received oxytocin for induction of labor.Induction was scheduled due to an intractable headache.She received magnesium sulfate therapy that was discontinued early due to hypotension.She received an epidural and spinal anesthesia for labor.The patient was noted to have abnormal postpartum bleeding related to uterine atony.Prior to jada insertion, the patient received txa (1 dose), carboprost (1 dose), and misoprostol.The patient's cumulative estimated blood loss at the time of jada insertion was reported at 1700 ml.Jada was inserted and in-dwelling for 10 minutes.Bleeding was noted as not controlled after jada placement.The patient then had bakri treatment following jada removal.She received red blood cells (2 units) and fresh frozen plasma (1 unit) after jada was removed.
 
Manufacturer Narrative
The post-jada medical interventions were necessary due to the patient's severe pph which was pre-existing prior to the use of jada.As we are unable to rule out the use of jada in contributing to the need for the subsequent interventions, we are reporting this as a mdr in an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer (Section G)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer Contact
richard ferrick
3495 edison way
menlo park, CA 94025
8445232666
MDR Report Key13030546
MDR Text Key286497668
Report Number3017425145-2021-00037
Device Sequence Number1
Product Code OQY
UDI-Device Identifier00850017882003
UDI-Public(01)00850017882003
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJADA-1001
Device Catalogue NumberJADA-1001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age33 YR
Patient SexFemale
Patient Weight119 KG
Patient RaceBlack Or African American
-
-